Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
3032700	s-goodpk	— (—)	488	564	100.00%	Distribution not available
3032700	s-goodpk	u/ml (u/ml)	27	174	0.00%

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Renal tubulo-interstitial diseases

274

177

11.93

233.16

1.7

1.1

67.33

64.98

u/ml

—

Condition for Implicit Sepsis (Organ dysfunction codes)

232

187

9.05

160.92

1.7

1.2

65.99

59.63

u/ml

—

Implicit Sepsis

212

187

8.85

150.17

1.8

1.1

61.99

9.00

u/ml

—

Heart failure, not strict

194

174

7.72

116.62

1.4

1.5

8.26

116.90

u/ml

—

Extracorporeal dialysis

34.40

89.64

3.2

1.0

116.95

—

u/ml

—

Other necrotizing vasculopathies

23.49

85.86

4.5

1.0

112.29

—

u/ml

—

ILD medications: immunosuppressive drugs

133

184

6.95

85.72

2.5

1.1

86.75

8.12

u/ml

—

All pneumoniae

197

278

4.90

78.34

1.5

63.45

54.48

u/ml

—

Influenza and pneumonia

201

272

4.87

77.78

1.5

56.59

57.78

u/ml

—

Pneumonias (Asthma/COPD co-morbidities)

194

278

4.85

76.31

1.5

63.45

54.48

u/ml

—

181

211

5.39

76.17

1.5

1.3

63.45

88.67

u/ml

—

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

181

211

5.39

76.17

1.5

1.3

63.45

88.67

u/ml

—

ILD medications: prednisolone, methylprednisolone, prednisone

201

224

5.08

76.03

1.8

1.1

38.95

5.88

u/ml

—

Pneumonia, organism unspecified

178

252

5.12

75.66

1.5

63.55

61.57

u/ml

—

ILD medications

204

229

4.90

73.37

1.8

1.1

41.78

5.88

u/ml

—

Other necrotizing vasculopathies (FG)

26.88

72.71

3.1

1.1

13.02

—

u/ml

—

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

189

282

4.72

72.63

1.5

63.55

54.48

u/ml

—

Bacterial infection, other or unspecified

120

167

6.50

70.93

1.2

1.5

76.17

14.86

u/ml

—

Other bacterial diseases

179

256

4.85

70.40

1.2

1.5

62.54

76.55

u/ml

—

First line medication for Crohn's disease

195

230

4.63

65.97

1.8

1.2

38.44

46.78

u/ml

—

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

180

290

4.46

65.32

1.2

1.6

4.08

77.59

u/ml

—

Kidney transplant status

34.02

62.57

3.5

1.0

107.20

—

u/ml

—

Fever of other and unknown origin

116

187

5.77

61.67

1.8

1.4

79.21

6.13

u/ml

—

Explicit Sepsis

126

6.72

55.04

1.4

1.1

103.14

10.46

u/ml

—

Transplanted organ and tissue status

15.84

54.62

3.3

1.0

93.33

—

u/ml

—

L04AD Calcineurin inhibitors

14.57

54.48

2.3

1.0

105.58

—

u/ml

—

Oral corticosteroids

178

271

3.98

52.79

1.5

1.2

43.61

52.89

u/ml

—

Septicaemia

138

6.08

49.55

1.4

1.7

103.14

14.86

u/ml

—

Inflammatory bowel disease treatment related agents

182

281

3.69

47.68

1.7

1.3

41.02

49.72

u/ml

0.06

Dyspnoea

149

303

3.77

44.89

1.4

185.43

6.93

u/ml

—

ILD medications: azathioprine

10.05

34.46

4.5

1.0

71.07

—

u/ml

—

Autoimmune diseases related-to ILD

124

324

3.37

33.18

2.8

1.0

112.29

6.70

u/ml

1.16

Hypertensive diseases

112

158

4.02

32.93

1.4

1.3

9.98

44.89

u/ml

—

Hypertension

112

158

4.02

32.92

1.4

1.3

9.98

44.89

u/ml

—

Abnormalities of breathing

124

209

3.53

31.36

1.3

1.4

180.80

8.89

u/ml

—

Azathioprine

8.34

29.96

4.5

1.0

71.07

—

u/ml

—

Bacterial pneumonia (organism specified)

177

4.18

29.71

1.7

1.2

99.64

15.78

u/ml

—

Persons encountering health services for specific procedures and health care

152

320

2.95

29.53

2.1

1.1

65.62

30.00

u/ml

—

Reimbursement for rheumatic diseases

243

3.70

28.74

2.8

1.1

95.33

61.81

u/ml

—

Autoimmune diseases excluding thyroid diseases

150

281

2.97

28.45

1.9

1.0

52.80

6.38

u/ml

—

Autoimmune diseases excluding thyroid diseases, strict definition

147

280

2.93

27.36

1.9

1.0

52.80

6.38

u/ml

—

COPD/asthma/ILD related infections

133

211

3.16

26.91

1.5

1.3

71.47

88.67

u/ml

—

COPD/asthma related infections

133

211

3.16

26.91

1.5

1.3

71.47

88.67

u/ml

—

Symptoms and signs involving the circulatory and respiratory systems

129

210

3.08

25.17

1.6

1.4

3.91

8.89

u/ml

—

L04AX Other immunosuppressants

246

3.34

22.51

2.7

1.2

61.61

87.57

u/ml

—

Asthma, excluding more controls

116

3.77

21.90

1.3

82.20

75.72

u/ml

—

Second line medication for Crohn's disease

253

3.25

21.54

2.7

1.2

61.61

87.57

u/ml

—

Diseases of arteries, arterioles and capillaries

241

3.04

21.38

1.7

1.2

54.16

9.24

u/ml

—

Tramadol

103

225

2.95

20.43

1.7

1.4

81.80

31.97

u/ml

—

Certain infectious and parasitic diseases

115

201

2.87

20.06

1.7

1.5

7.71

51.70

u/ml

—

Autoimmune diseases

138

281

2.51

19.03

2.2

1.0

11.66

6.38

u/ml

—

Asthma (mode)

141

3.28

18.73

1.3

68.73

75.72

u/ml

—

Other pulmonary diagnosis

139

3.21

18.61

1.6

1.3

9.00

75.72

u/ml

—

Cardiomyopathy, other and unspecified

12.92

18.55

1.0

—

Asthma

139

3.24

18.32

1.3

82.20

75.72

u/ml

—

Diabetes, varying definitions

125

299

2.50

17.98

1.3

1.5

102.30

49.82

u/ml

—

Asthma (only as main-diagnosis), excluding more controls

116

3.50

17.20

1.1

1.3

77.08

75.72

u/ml

—

Diabetes mellitus

122

301

2.42

16.47

1.3

1.5

102.30

49.82

u/ml

—

Pain in throat and chest

203

2.77

16.27

1.3

1.4

11.15

8.89

u/ml

—

Examination and observation for other reasons

191

2.80

15.87

1.0

1.8

—

46.96

—

Polyarthropathies

224

2.71

15.86

1.0

1.4

—

60.43

—

Used for control exclusion in common control thyroid runs

126

270

2.37

15.49

1.9

1.0

11.05

6.38

u/ml

—

Disorders of lipoprotein metabolism and other lipidaemias

237

2.58

15.11

1.0

1.6

—

67.09

—

Complications of surgical and medical care, not elsewhere classified

114

355

2.30

14.58

1.7

1.3

68.75

53.76

u/ml

—

Asthma (only as main-diagnosis)

139

3.04

14.49

1.1

1.3

77.08

75.72

u/ml

—

Diabetes medication

118

317

2.26

13.92

1.3

1.4

102.30

49.82

u/ml

—

Glucagon-like peptide-1 (GLP-1) analogues

230

2.69

13.65

1.5

102.30

45.15

u/ml

—

Complications of procedures, not elsewhere classified

341

2.38

13.56

1.3

101.74

53.76

u/ml

—

Abnormal findings on examination of blood, without diagnosis

227

2.68

12.21

1.6

1.4

71.57

10.06

u/ml

—

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

105

288

2.23

12.03

1.2

1.5

6.50

52.67

u/ml

—

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

104

337

2.10

10.63

2.0

1.3

107.14

50.24

u/ml

—

Diseases of the skin and subcutaneous tissue

112

270

2.08

10.38

1.5

1.4

9.04

56.61

u/ml

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

3.55

10.19

1.1

—

77.06

—

Hypertensive Renal Disease

11.08

10.17

1.1

1.0

—

Diabetes, insulin treatment (Kela reimbursement)

109

328

2.03

10.05

1.2

1.5

6.50

76.41

u/ml

—

Diarrhoea and gastroenteritis of presumed infectious origin

324

2.16

9.08

1.4

97.76

35.78

u/ml

—

Codeine or tramadol medication

119

351

1.88

8.64

1.3

1.4

8.34

68.47

u/ml

—

115

319

1.90

8.59

1.7

1.4

4.60

91.86

u/ml

—

Other disorders of gingiva or/and edentulous alveolar ridge

7.54

8.41

1.0

—

Other diseases of urinary system

104

303

1.93

8.25

1.4

1.5

19.03

72.00

u/ml

—

Hyperlipidaemia, other/unspecified

157

2.60

7.74

1.0

1.6

—

13.87

—

Persons encountering health services for specific procedures, not carried out

5.93

7.38

1.0

—

Gingival hyperplasia

15.85

7.23

1.0

—

Pure hypercholesterolaemia

222

2.09

7.09

1.0

1.6

—

48.05

—

Myocardial infarction

180

2.24

6.93

1.1

1.6

—

11.04

—

Chronic lower respiratory diseases

117

367

1.73

6.55

1.3

1.5

69.32

50.97

u/ml

—

Parodontitis and operation codes

353

1.83

6.12

1.7

1.3

104.94

53.70

u/ml

—

Intestinal infectious diseases

395

1.77

6.02

1.3

1.5

97.76

47.25

u/ml

—

Parodontitis

357

1.80

6.01

1.7

1.3

104.94

51.95

u/ml

—

Parodontitis or operation codes

357

1.80

6.00

1.7

1.3

104.94

51.95

u/ml

—

Chronic periodontitis, including avohilmo

358

1.78

5.76

1.7

1.3

104.94

51.95

u/ml

—

Symptoms and signs involving the urinary system

320

1.84

5.70

1.6

1.3

8.76

60.69

u/ml

—

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

4.50

5.51

1.2

1.0

—

Complications of cardiac and vascular prosthetic devices, implants and grafts

16.16

5.42

1.0

—

Myocardial infarction, strict

174

2.10

5.41

1.1

1.6

—

12.11

—

Gingivitis and periodontal diseases

247

1.78

5.29

1.6

1.3

7.63

54.19

u/ml

—

COPD, hospital admissions 3, with asthma pneumonia sepsis

121

2.39

5.17

1.0

1.2

—

11.79

—

Anxiety (asthma-related co-morbidities)

210

1.99

5.10

1.1

1.5

—

34.40

—

Bronchitis

390

1.65

4.96

1.9

1.3

4.07

77.00

u/ml

—

Unspecified nephritic syndrome

11.52

4.79

1.0

—

Gastroduodenal ulcer

121

2.39

4.59

1.1

1.5

—

15.43

—

Multiple myeloma

14.10

4.58

1.0

—

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS)

14.10

4.58

1.0

—

Elevated blood glucose level

4.24

4.35

1.0

—

All anxiety disorders

234

1.86

4.34

1.1

1.5

—

33.31

—

Myocardial infarction, without ST-elevation

187

2.02

4.31

1.0

1.4

—

10.61

—

COPD related to multimorbidity

170

2.03

4.28

1.0

1.6

—

10.85

—

Asthma, hospital admissions , main diagnosis only

389

1.68

4.27

1.1

1.6

77.08

52.23

u/ml

—

COPD, hospital admission 2, with asthma infections

140

2.13

4.17

1.0

1.2

—

11.79

—

Obesity due to excess calories

208

1.97

4.09

1.1

1.3

—

60.80

—

Primary_lymphoid and hematopoietic malignant neoplasms

116

2.33

4.07

1.0

1.5

—

13.72

—

Nerve, nerve root and plexus disorders

369

1.58

4.07

1.3

1.4

154.93

26.70

u/ml

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

343

1.61

4.04

1.5

1.4

8.94

71.87

u/ml

—

Pericarditis

10.04

4.01

1.0

—

Personality disorders, excluding more controls

2.37

3.64

1.0

1.2

—

6.46

—

Anxiety disorders, excluding more controls

289

1.63

3.57

1.1

1.6

—

53.32

—

Anxiety disorders

344

1.59

3.53

1.1

1.5

—

69.50

—

Other obstructive and reflux uropathy

10.03

3.50

1.0

—

Neurotic, stress-related and somatoform disorders

341

1.58

3.47

1.1

1.5

—

69.50

—

Asthma, including avohilmo

102

399

1.49

3.37

1.2

1.5

68.73

48.77

u/ml

—

Acute upper respiratory infections

373

1.51

3.29

1.9

1.3

5.11

76.77

u/ml

—

Allergic asthma (mode)

2.61

3.26

1.1

1.0

—

Sicca syndrome [Sjögren]

3.34

2.90

1.1

1.0

—

Hypersensitivity pneumonitis due to organic dust

8.39

2.75

1.0

—

Methotrexate

2.86

2.74

1.1

1.0

—

Giant cell arteritis

5.02

2.73

1.0

—

Later onset COPD

119

1.92

2.66

1.1

1.2

—

10.56

—

Pain (limb, back, neck, head abdominally)

215

1.54

2.57

1.1

1.5

—

35.02

—

Attention to artificial openings

7.16

2.55

1.2

1.0

—

Giant cell arteritis with polymyalgia rheumatica

5.48

2.54

1.0

1.1

—

Diseases of pulp and periapical tissues, including avohilmo

328

1.43

2.47

1.5

3.90

52.30

u/ml

—

Cardiodefibrillation

187

1.76

2.46

1.0

1.5

—

11.66

—

Coxarthrosis, primary, with hip surgery

221

1.67

2.41

1.0

1.5

—

49.50

—

Temporal arteritis

5.02

2.40

1.0

—

Other postsurgical states

4.13

2.36

1.0

—

Psychiatric diseases

325

1.40

2.29

1.0

1.6

—

44.33

—

Medical abortion

143

1.63

2.23

1.0

1.6

—

129.14

—

Myocardial infarction, with ST-elevation

2.05

2.10

1.1

1.2

—

11.50

—

Alzheimer disease, including avohilmo

141

0.41

2.09

1.0

1.2

—

13.53

—

Dorsopathies

329

1.38

2.09

1.5

8.52

54.44

u/ml

—

Dorsalgia

326

1.38

1.97

1.5

8.52

56.59

u/ml

—

Polyarthrosis

2.07

1.93

1.0

1.5

—

88.52

—

Other anxiety disorders

180

1.63

1.88

1.1

1.6

—

8.84

—

Lichen sclerosus et atrophicus

2.57

1.80

1.0

1.1

—

COPD, hospital admissions 1, only main diagnosis

158

1.62

1.69

1.0

1.7

—

11.83

—

Rheumatoid arthritis

121

1.73

1.66

1.0

1.6

—

64.94

—

Hallux valgus (acquired)

101

1.72

1.65

1.0

1.4

—

117.66

—

Chronic rhinitis, nasopharyngitis and pharyngitis

145

1.66

1.53

1.0

1.4

—

7.65

—

Coronary angioplasty

146

1.58

1.53

1.0

1.7

—

13.01

—

Disorders of adult personality and behaviour

116

1.73

1.48

1.1

—

6.46

—

Injuries to the hip and thigh

222

1.48

1.45

1.0

1.2

—

10.21

—

Psoriatic and enteropathic arthropathies

2.37

1.45

1.1

1.0

—

Alzheimer disease

118

0.45

1.45

1.0

1.2

—

13.53

—

Other dorsopathies, not elsewhere classified

327

1.31

1.44

1.5

1.4

8.52

56.59

u/ml

—

Asthma and opportunity respiratory infection

3.13

1.44

1.0

1.1

—

Budesonide

2.31

1.43

1.0

—

Malignant neoplasm of respiratory system and intrathoracic organs, excluding all cancers (controls excluding all cancers)

105

1.68

1.39

1.0

1.5

—

7.92

—

Disorders of gallbladder, biliary tract and pancreas

361

1.30

1.34

1.4

101.58

45.16

u/ml

—

Epilepsy

151

1.59

1.33

1.1

1.4

—

8.23

—

Pacemaker

158

1.54

1.23

1.1

1.2

—

10.56

—

Use of memantine

110

0.47

1.17

1.0

1.2

—

13.53

—

Use of other anti-dementia drugs

110

0.47

1.17

1.0

1.2

—

13.53

—

Symptoms and signs involving speech and voice

157

1.53

1.17

1.0

1.3

—

11.72

—

Pregnancy with abortive outcome

145

1.41

1.14

1.0

1.6

—

129.14

—

Use of hypnotics and sedatives

363

1.26

1.13

2.2

1.2

9.53

63.87

u/ml

—

Inflammatory diseases of female pelvic organs

174

1.43

1.13

1.1

1.5

—

117.49

—

Trigger finger

1.90

1.12

1.0

—

Malignant neoplasm of breast, HER-positive

136

0.51

1.09

1.1

1.6

—

129.87

—

Injury of muscle and tendon at shoulder and upper arm level

193

1.45

1.08

1.0

1.5

—

15.46

—

Organic, including symptomatic, mental disorders

193

1.38

1.07

1.0

1.6

—

43.50

—

Degenerative diseases of the nervous system

136

0.55

1.05

1.1

1.2

—

11.79

—

Combinations of oral blood glucose lowering drugs

129

1.55

1.05

1.1

1.6

—

10.52

—

Papulosquamous disorders

187

1.44

1.03

1.1

1.3

—

14.16

—

Other shoulder lesions

2.06

1.02

1.1

1.0

—

Follow-up examination after treatment for conditions other than malignant neoplasms

143

1.42

1.02

1.1

1.7

—

66.42

—

Any mental disorder

338

1.23

0.98

1.0

1.5

—

44.33

—

Reactive arthropathies, FINNGEN

2.18

0.98

1.0

—

Malignant neoplasm of bronchus and lung, excluding all cancers (controls excluding all cancers)

1.59

0.98

1.0

1.6

—

7.92

—

Other benign neoplasms of skin

170

1.44

0.96

1.0

1.4

—

41.52

—

Any dementia

149

0.61

0.94

1.0

1.2

—

10.56

—

Alzheimer’s disease, wide definition

101

0.50

0.94

1.0

1.3

—

13.53

—

L02BG Aromatase inhibitors

118

0.51

0.93

1.2

1.7

—

181.28

—

Medicines for HER+ breast cancer

141

0.55

0.93

1.1

1.5

—

129.87

—

conjunctival haemorrhage

2.07

0.89

1.0

—

Infectious mononucleosis

2.07

0.89

1.2

1.1

—

Artrosis, including avohilmo

272

1.25

0.89

1.0

1.4

—

27.69

—

Malignant neoplasm of breast, ER-positive, excluding all cancers (controls excluding all cancers)

107

0.53

0.88

1.1

1.4

—

149.35

—

Spontaneous abortion

116

0.59

0.88

1.0

1.6

—

102.38

—

Other benign neoplasms of skin

177

1.41

0.88

1.0

1.3

—

10.19

—

Other functional intestinal disorders

193

1.38

0.87

1.0

1.7

—

12.13

—

Degeneration of macula and posterior pole

196

1.35

0.84

1.0

1.6

—

45.09

—

Open wound of head

278

1.31

0.84

1.0

1.6

—

10.35

—

Other intervertebral disc disorders

297

1.24

0.81

1.9

1.4

77.52

63.57

u/ml

—

Conduction disorders

1.56

0.81

1.0

1.5

—

8.46

—

Rheumatoid arthritis, including avohilmo

181

1.38

0.79

1.0

1.3

—

14.13

—

Inflammatory disorders of breast

0.00

0.79

0.0

1.0

—

Synovial cyst of popliteal space [Baker]

1.82

0.79

1.0

1.1

—

Any dementia, excluding more controls

137

0.66

0.74

1.0

1.4

—

9.19

—

Persons encountering health services in other circumstances, wide

390

1.17

0.69

1.6

1.5

8.26

69.60

u/ml

—

Malignant neoplasm of respiratory system and intrathoracic organs

109

1.44

0.67

1.0

1.2

—

9.75

—

Injuries to the abdomen, lower back, lumbar spine and pelvis

195

1.32

0.66

1.0

1.3

—

10.21

—

Unspecific neurodegenerative disorder

155

0.71

0.63

1.0

1.4

—

10.83

—

Benign neoplasm: Colon, unspecified

129

1.40

0.63

1.1

1.4

—

13.72

—

Redundant prepuce, phimosis and paraphimosis

120

1.41

0.63

1.1

1.5

—

10.60

—

Infections with a predominantly sexual mode of transmission

112

1.43

0.63

1.2

—

6.46

—

Alzheimer’s disease (Late onset)

0.57

0.62

1.0

1.2

—

11.44

—

Excessive vomiting in pregnancy

1.67

0.61

1.0

—

Prolapse and hernia of ovary and fallopian tube

0.00

0.60

0.0

1.1

—

Unspecified mental disorder

209

1.29

0.60

1.0

1.3

—

6.11

—

Schizophrenia or delusion, excluding more controls

138

1.37

0.60

1.0

1.6

—

6.26

—

Impotence

0.00

0.59

0.0

1.0

—

Radial styloid tenosynovitis [de Quervain]

0.00

0.59

0.0

1.0

—

Seborrhoeic keratosis

1.41

0.54

1.0

1.5

—

13.72

—

Fracture of femur

114

1.36

0.53

1.0

1.1

—

11.44

—

Plantar fascial fibromatosis

1.54

0.53

1.0

—

General examination and investigation of persons without complaint and reported diagnosis

194

1.21

0.53

1.1

1.8

—

43.90

—

Tonsillectomy and adenotomy

190

0.77

0.52

1.1

1.4

—

40.09

—

135

1.31

0.50

1.0

1.5

—

13.37

—

Localized swelling, mass and lump of skin and subcutaneous tissue

153

1.31

0.50

1.0

1.4

—

11.60

—

Diseases of external ear

171

1.29

0.49

1.0

1.3

—

13.72

—

Other disorders of penis

1.49

0.47

1.0

—

Dental caries 3 and operation codes, only avohilmo

107

0.75

0.47

1.0

1.8

—

83.81

—

Myocardial infarction, unclassifiable

106

0.67

0.46

1.0

1.3

—

11.79

—

Spondylopathies (FG)

1.43

0.46

1.0

—

Dental caries 1 and operation codes, only avohilmo

0.73

0.44

1.0

2.0

—

91.70

—

Gestational [pregnancy-induced] oedema and proteinuria without hypertension

1.61

0.43

1.0

—

Benign neoplasm: Adrenal gland

1.56

0.42

1.0

—

Haemorrhoids and perianal venous thrombosis

131

1.30

0.41

1.1

1.4

—

18.43

—

Other benign neoplasm of uterus: Other parts/unspecified

0.00

0.41

0.0

1.0

—

Other benign neoplasm of uterus: Other parts/unspecified

0.00

0.41

0.0

1.1

—

Infections of breast associated with childbirth

0.00

0.41

0.0

1.0

—

Specific development disorders of scholastic skills

0.00

0.41

0.0

1.0

—

Complications of the puerperium, not elsewhere classified

0.00

0.40

0.0

1.0

—

Labour and delivery complicated by intrapartum haemorrhage, not elsewhere classified

0.00

0.40

0.0

1.0

—

Primary coxarthrosis, bilateral

141

1.28

0.40

1.0

1.4

—

13.72

—

Erosion and ectropion of cervix uteri

0.00

0.40

0.0

1.1

—

Migraine

166

1.23

0.39

1.0

1.5

—

113.11

—

Lesion of plantar nerve

0.00

0.39

0.0

1.0

—

Atopic dermatitis, strict definition with reimbursement

112

1.30

0.37

1.1

1.6

—

10.88

—

Nontraumatic intracranial haemmorrhage

1.33

0.37

1.1

1.2

—

11.50

—

Colorectal cancer

124

0.73

0.35

1.1

1.4

—

11.75

—

Malignant neoplasm of bronchus and lung

1.31

0.34

1.0

1.2

—

9.75

—

Puerperal sepsis

1.30

0.33

1.0

—

Embedded and impacted teeth

1.29

0.30

1.0

1.8

—

11.00

—

Acute appendicitis, no complications

295

1.15

0.30

1.0

1.3

—

42.54

—

Injuries to the thorax

239

0.84

0.29

1.1

1.4

—

9.34

—

Benign mammary dysplasia

1.23

0.29

1.1

1.0

—

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

162

0.80

0.28

1.0

1.4

—

7.42

—

Polycystic ovarian syndrome, consortium definition

179

1.15

0.28

1.0

1.5

—

117.49

—

Kela-code for severe mental illness

186

1.18

0.27

1.0

1.3

—

6.11

—

Malignant neoplasm of digestive organs

190

0.83

0.26

1.1

1.6

—

11.83

—

Poisoning by drugs, medicaments and biological substances

1.26

0.26

1.1

1.2

—

6.72

—

Long labour

1.21

0.25

1.0

1.1

—

76.94

—

Irregular menses

138

1.18

0.23

1.0

1.5

—

102.33

—

Other and unspecified disease of Bartholin gland

0.00

0.21

0.0

1.0

—

Benign neoplasm of other and unspecified sites

0.00

0.21

0.0

1.0

—

Benign neoplasm: Long bones of lower limb

0.00

0.21

0.0

1.0

—

Muscle strain

0.00

0.21

0.0

1.0

—

Hypoparathyroidism

0.00

0.21

0.0

1.0

—

TMD related pain

0.00

0.21

0.0

1.0

—

Bulimia nervosa (incl. atypical)

0.00

0.21

0.0

1.0

—

Other disorders of male genital organs

0.00

0.21

0.0

1.0

—

Asthma mixed form (mode)

0.00

0.21

0.0

1.0

—

Premature separation of placenta [abruptio placentae]

0.00

0.21

0.0

1.0

—

Benign neoplasm: Small intestine

0.00

0.21

0.0

1.0

—

Female infertility, tubal origin

0.00

0.21

0.0

1.0

—

Dementia, including avohilmo

166

0.87

0.20

1.0

1.5

—

46.75

—

Family history of certain disabilities and chronic diseases leading to disablement

0.00

0.20

0.0

1.0

—

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

114

0.79

0.20

1.1

1.2

—

6.60

—

Other hearing loss

135

1.16

0.18

1.1

1.4

—

13.64

—

Obstructed labour due to malposition and malpresentation of fetus

0.76

0.17

1.0

1.1

—

76.94

—

Other reaction to severe stress, and adjustment disorders

149

1.14

0.15

1.1

1.4

—

7.55

—

Fissure and fistula of anal and rectal regions

112

1.16

0.14

1.0

1.5

—

13.72

—

N06DA Anticholinesterases

138

0.88

0.14

1.0

1.2

—

11.79

—

Use of anticholinesterases

138

0.88

0.14

1.0

1.2

—

11.79

—

Atopic dermatitis, strict definition

120

1.14

0.13

1.1

1.6

—

9.35

—

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

108

0.83

0.13

1.1

1.2

—

5.77

—

Functional dyspepsia

114

1.14

0.11

1.0

1.4

—

7.72

—

Other degenerative diseases of the nervous system

104

0.87

0.11

1.1

2.2

—

64.19

—

Acute appendicitis

365

1.06

0.10

1.0

1.5

—

53.50

—

Triptan medication for migraine, min. 3 purchases

180

0.92

0.09

1.0

1.5

—

86.33

—

Benign neoplasm of breast

1.04

0.09

1.0

—

Malignant neoplasm of digestive organs, excluding all cancers (controls excluding all cancers)

189

1.07

0.09

1.0

1.4

—

50.53

—

Deviated nasal septum

194

0.93

0.07

1.0

1.6

—

13.41

—

Acute suppurative otitis media

101

1.11

0.07

1.1

1.7

—

11.00

—

Dementia

148

0.93

0.07

1.0

1.6

—

46.75

—

Colorectal adenocarcinoma, excluding all cancers (controls excluding all cancers)

0.89

0.06

1.1

1.6

—

7.92

—

Inflammatory bowel disease

158

1.08

0.06

1.1

1.2

—

7.56

—

Macular pucker

1.09

0.03

1.0

1.6

—

13.72

—

Striking against or struck by other objects

168

0.95

0.02

1.6

1.3

—

5.94

—

Colorectal cancer, excluding all cancers (controls excluding all cancers)

128

1.06

0.02

1.1

1.4

—

7.92

—

Persons encountering health services in other circumstances

193

1.04

0.01

1.1

1.4

—

10.38

—

Mouth breathing

226

0.97

0.00

1.0

1.4

—

8.17

—

Appendicitis, broad definition

379

1.01

0.00

1.0

1.5

—

50.92

—

Secondary uncertain malignant neoplasm, excluding all cancers (controls excluding all cancers)

190

1.02

0.00

1.0

1.4

—

50.53

—

Contraceptive management

125

1.01

0.00

1.1

1.3

—

148.55

—

Diseases of appendix

380

1.01

0.00

1.0

1.5

—

50.91

—

severe traumatic brain injury, does not include concussion

108

1.02

0.00

1.0

1.2

—

11.50

—

Other diseases of appendix

0.00

0.0

1.0

—

Benign neoplasm: Lip

0.00

0.0

1.0

—

Disorders of synovium and tendon in diseases classified elsewhere

0.00

0.0

1.0

—

Benign neoplasm: Vulva

0.00

0.0

1.0

—

Tuberculosis of other organs

0.00

0.0

1.0

—

Other maltreatment syndromes

0.00

0.0

1.0

—

Lagophthalmos

0.00

0.0

1.0

—

Benign neoplasm: Vulva

0.00

0.0

1.0

—

Acute otitis externa, noninfective

0.00

0.0

1.0

—

Malignant neoplasm of oropharynx, excluding all cancers (controls excluding all cancers)

0.00

0.0

1.0

—

Moderate visual impairment, binocular

0.00

0.0

1.1

—

Tuberculosis of other organs, strict

0.00

0.0

1.0

—

Benign neoplasm: Lip

0.00

0.0

1.0

—

Inflammation of lacrimal passages (acute and unspecified)

0.00

0.0

1.0

—

Procedures for purposes other than remedying health state

0.00

0.0

1.0

—

Distal bite

0.00

0.0

1.1

—

HSIL lesion of the vagina

0.00

0.0

1.0

—

Other assisted single delivery

0.00

0.0

1.0

—

Benign neoplasm: Short bones of upper limb

0.00

0.0

1.0

—

Viral and other specified intestinal infections

0.94

0.00

1.0

1.6

—

9.55

—

Wide developmental disorders

0.00

0.0

1.0

—

Drug-induced adrenocortical insufficiency

0.00

0.0

1.0

—

Hirsutism in women

0.00

0.0

1.0

—

Right bundle-branch block

0.00

0.0

1.0

—

Autism spe

0.00

0.0

1.0

—

Other and unspecified hydrocephalus

0.00

0.0

1.0

—

Other and unspecified acute skin changes due to ultraviolet radiation

0.00

0.0

1.0

—

Chronic crepitant synovitis/bursitis of hand and wrist/periarthritis of wrist

0.00

0.0

1.0

—

Habitual aborter

0.00

0.0

1.0

—

Endometriosis of fallopian tube

0.00

0.0

1.0

—

Calcaneal spur

0.00

0.0

1.0

—

Benign neoplasm of other and unspecified sites

0.00

0.0

1.0

—

Primary ovarian failure

0.00

0.0

1.0

—

Autoimmune thyroiditis

0.00

0.0

1.0

—

Xanthelasma of eyelid

0.00

0.0

1.0

—

Use of glatiramer acetate

0.00

0.0

1.0

—

Bursitis of shoulder

0.00

0.0

1.0

—

Use of interferon beta-1a

0.00

0.0

1.0

—

Malignant neoplasm of vulva, excluding all cancers (controls excluding all cancers)

0.00

0.0

1.0

—

Hypertrichosis

0.00

0.0

1.0

—

Malignant cancer of tonsil and base of tongue, excluding all cancers (controls excluding all cancers)

0.00

0.0

1.0

—

Autism

0.00

0.0

1.0

—

0.00

0.0

1.1

—

6-mercaptopurine

0.00

0.0

1.0

—

Epiphora

0.00

0.0

1.0

—

Lack of expected normal physiological development

0.00

0.0

1.2

—

Malignant neoplasm of other and unspecified female genital organs

0.00

0.0

1.0

—

Contusion of toe(s) without damage to nail

0.00

0.0

1.0

—

Malignant neoplasm of other and unspecified female genital organs, excluding all cancers (controls excluding all cancers)

0.00

0.0

1.0

—

Crystal arthropathies, rheuma endpoint

0.00

0.0

1.1

—

Benign neoplasm: Pancreas

0.00

0.0

1.0

—

Torsion of testis

0.00

0.0

1.0

—

Benign neoplasm: Other/unspecified site

0.00

0.0

1.0

—

Varus deformity, not elsewhere classified

0.00

0.0

1.0

—

Benign neoplasm: Connective and other soft tissue of lower limb, including hip

0.00

0.0

1.0

—

Injury of urinary and pelvic organs

0.00

0.0

1.0

—

Personal history of malignant neoplasm

0.00

0.0

1.0

—

Benign neoplasm: Short bones of upper limb

0.00

0.0

1.0

—

Pterygium

0.00

0.0

1.0

—

Asthma mixed form (mode), excluding more controls

0.00

0.0

1.0

—

Assault by unspecified means

0.00

0.0

1.0

—

Inflammatory disorders of male genital organs, not elsewhere classified

0.00

0.0

1.0

—

0.00

0.0

1.0

—

0.00

0.0

1.2

—

Mumps

0.00

0.0

1.0

—

Mental and behabioural disorders of puerperum, not classified elsewhere, excluding more controls

0.00

0.0

1.0

—

Carcinoma in situ of breast, other/unspecified

0.00

0.0

1.0

—

Benign neoplasm: Tongue

0.00

0.0

1.0

—

Juvenile rheumatoid arthirtis

0.00

0.0

1.0

—

Juvenile osteochondrosis

0.00

0.0

1.0

—

Benign neoplasm: Other/unspecified site

0.00

0.0

1.0

—

Benign neoplasm: Duodenum

0.00

0.0

1.0

—

Benign neoplasm: Connective and other soft tissue of lower limb, including hip

0.00

0.0

1.0

—

conjunctival degenerations and deposits

0.00

0.0

1.0

—

Benign neoplasm: Other and unspecified parts of small intestine

0.00

0.0

1.0

—

Myasthenia gravis

0.00

0.0

1.0

—

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Glomerular basement membrane Ab [Units/volume] in Serum

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS